Coronary Microvascular Disease (CMD) Registry
The purpose of this project is to provide appropriate administrative and technical supports for the warehousing and use of a database of patients with coronary microvascular disease (CMD). This protocol will outline the process for identification and capture of data, storage, as well as data use and sharing internally and externally for research purposes.
Conditions:
🦠 Coronary Microvascular Dysfunction
🗓️ Study Start (Actual) 1 February 2023
🗓️ Primary Completion (Estimated) January 2033
✅ Study Completion (Estimated) January 2033
👥 Enrollment (Estimated) 1000
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Washington, District of Columbia, United States
📍 Hollywood, Florida, United States
📍 Clinton, Maryland, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Those with Coronary Microvascular Disease
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 17 July 2023
  • First Submitted that Met QC Criteria 17 July 2023
  • First Posted 25 July 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 6 June 2024
  • Last Update Posted 7 June 2024
  • Last Verified June 2024